NBC Securities Inc. Has $520,000 Holdings in Progyny, Inc. (NASDAQ:PGNY)

NBC Securities Inc. boosted its stake in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) by 97,037.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 23,313 shares of the company's stock after buying an additional 23,289 shares during the period. NBC Securities Inc.'s holdings in Progyny were worth $520,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Signaturefd LLC increased its position in shares of Progyny by 1,355.0% during the fourth quarter. Signaturefd LLC now owns 1,455 shares of the company's stock worth $25,000 after acquiring an additional 1,355 shares in the last quarter. Caitlin John LLC boosted its stake in Progyny by 2,974.8% in the 4th quarter. Caitlin John LLC now owns 3,290 shares of the company's stock worth $57,000 after purchasing an additional 3,183 shares during the period. Natixis bought a new position in Progyny during the 4th quarter worth about $69,000. SBI Securities Co. Ltd. bought a new position in Progyny during the 4th quarter worth about $74,000. Finally, KBC Group NV raised its stake in shares of Progyny by 84.6% in the 4th quarter. KBC Group NV now owns 4,669 shares of the company's stock valued at $81,000 after purchasing an additional 2,140 shares during the period. 94.93% of the stock is currently owned by institutional investors and hedge funds.

Progyny Trading Up 1.3%

Shares of NASDAQ:PGNY traded up $0.29 during trading on Monday, hitting $21.97. 822,748 shares of the company were exchanged, compared to its average volume of 1,707,167. Progyny, Inc. has a fifty-two week low of $13.39 and a fifty-two week high of $30.42. The stock has a market cap of $1.88 billion, a price-to-earnings ratio of 37.88, a P/E/G ratio of 2.39 and a beta of 1.32. The firm has a fifty day moving average price of $22.02 and a two-hundred day moving average price of $20.43.

Progyny (NASDAQ:PGNY - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $0.17 earnings per share for the quarter, missing analysts' consensus estimates of $0.45 by ($0.28). Progyny had a return on equity of 11.36% and a net margin of 5.03%. The firm had revenue of $324.04 million for the quarter, compared to analyst estimates of $307.86 million. During the same quarter in the previous year, the firm posted $0.17 earnings per share. Progyny's quarterly revenue was up 16.5% on a year-over-year basis. As a group, research analysts predict that Progyny, Inc. will post 0.6 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently weighed in on PGNY shares. Canaccord Genuity Group reduced their price objective on Progyny from $23.00 to $21.00 and set a "hold" rating for the company in a research report on Monday, May 12th. BTIG Research upgraded Progyny from a "neutral" rating to a "buy" rating and set a $28.00 target price on the stock in a research note on Monday, March 31st. Finally, Bank of America upped their price target on Progyny from $21.00 to $25.00 and gave the stock a "buy" rating in a research report on Tuesday, February 11th. Seven research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $23.45.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.